Epigenetic Markers for Pancreatic Carcinogenesis


Epigenetic Markers for Pancreatic Carcinogenesis Columbia University Medical Center

Secondary data analysis to be conducted within the prospective observational study, also known as the, PREDICT cohort (IRB #AAAA6154) protocol. In this analysis we will examine the association of pancreatic adenocarcinoma with epigenetics and modifiable factors (e.g., diet, lifestyle) using previously collected samples and questionnaire data. Our analysis will examine the association between DNA methylation (epigenetics) and pancreatic adenocarcinoma.

Are you Eligible? (Inclusion Criteria)


  1. Tissue-confirmed diagnosis of pancreatic adenocarcinoma.
  2. No previous treatment received
  3. Underwent surgical resection for adenocarcinoma at Columbia Presbyterian Medical Center 
  4. Older than 18 years


  1. Previous treatment received 
  2. 18 years old or less

Specialty Area(s)

Trial Location

Columbia University Medical Center
HIP (The Herbert Irving Pavilion)
8th Floor
New York, NY 10032
United States